131 results
DEFC14A
DMKPQ
DMK Pharmaceuticals Corp
12 Oct 23
Proxy in contested solicitation
4:22pm
, compensation, retention and oversight of the independent registered public accounting firm, the Audit Committee and our Board are requesting, as a matter
PREC14A
DMKPQ
DMK Pharmaceuticals Corp
2 Oct 23
Preliminary proxy with contested solicitation
4:49pm
interest in the Company.
While the Audit Committee is responsible for the appointment, compensation, retention and oversight of the independent
8-K
EX-1.1
DMKPQ
DMK Pharmaceuticals Corp
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
have no duties or liabilities to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention
DEFM14A
wou1nig8vq l25z
13 Apr 23
Proxy related to merger
4:52pm
8-K
EX-10.1
faii6
18 May 22
Adamis Pharmaceuticals Announces Leadership Transition to Support New Phase of Innovation and Growth
7:53pm
8-K
EX-14.1
719ejl9y94xd94xlk0
18 Feb 22
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:43pm